TUCSON, Ariz., June 9, 2026 — Critical Path Institute® (C-Path) will host its 2026 Global Impact Conference (CGIC) this September at the Washington Marriott at Metro Center in Washington, D.C. The ...
TUCSON, Ariz., July 22, 2025 — Stakeholders across the life sciences ecosystem are invited to attend the 2025 Critical Path Institute® (C-Path) Global Impact Conference (CGIC), taking place Sept. 9–11 ...
Critical Path Institute® (C-Path), through its Type 1 Diabetes Consortium, today reaffirmed its commitment to strengthening ...
As drug developers pursue increasingly complex therapies, traditional bioanalytical approaches are being put to the test. How ...
The pharmaceutical industry is experiencing its own “DeepSeek moment,” according to science writer Hiya Jain. Just as the upstart AI breakthrough caught Silicon Valley off-guard, China is emerging as ...
Pediatric drug development faces significant challenges, including underfunding, ethical concerns, and complex regulatory frameworks. Despite significant advances in adult drug development, children ...
Patient organizations are reshaping rare disease drug development where conventional systems falter by integrating patient expertise, scientific stewardship, R&D infrastructure and cross-sector ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results